<DOC>
	<DOCNO>NCT01699490</DOCNO>
	<brief_summary>The purpose study identify evidence-based guideline treat major depressive disorder full remission Taiwanese major depressive disorder ( MDD ) patient . To achieve goal , investigator aim : ( 1 ) evaluate risk benefit adjunctive pharmacotherapies cognitive metabolic consequence MDD , ( 2 ) clarify share biological mechanism mood , immune metabolism homeostasis</brief_summary>
	<brief_title>Role Inflammation Factors Insulin Resistance Major Depressive Disorder</brief_title>
	<detailed_description>The prevalence insulin resistance significantly differ among healthy control drug-naïve MDD patient antidepressant treatment . Meanwhile , current study indicate antidepressant might affect insulin secretion independently therapeutic effect MDD . Therapeutic strategy consider treatment effectiveness glucose-insulin homeostasis MDD patient necessary .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Age : 1665 year old Signed informed consent patient legal representative Hamilton Rating Scale Depression ( HDRS ) score ≥ 16 A diagnosis MDD accord DSMIV criterion make specialist psychiatry Monoamine oxidase inhibitor antidepressant treatment prior enter study A DSMIV diagnosis substance abuse within past three month An organic mental disease , mental retardation dementia A serious surgical condition physical illness Patients pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>Insulin</keyword>
	<keyword>Fluoxetine</keyword>
</DOC>